Department of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Exp Neurol. 2012 Jan;233(1):350-6. doi: 10.1016/j.expneurol.2011.10.027. Epub 2011 Nov 4.
This study aimed to investigate the feasibility of targeted gene transfer into central nervous system (CNS) by MRI-guided focused ultrasound-induced blood-brain barrier (BBB) disruption. Before each sonication, T2-weighted images were obtained to select the target region. Followed by injecting DNA-loaded microbubbles into the tail vein, sonication was performed. The state of local BBB, distribution of plasmid DNA through the opened BBB, the ultrastructural changes of neurons and BDNF expression were detected. The results showed that MRI-guided focused ultrasound (FUS) could accomplish noninvasive, transient, and local BBB disruption, at 1h after sonication, plasmid DNA across the opened BBB had been internalized into the neurons presenting heterogeneous distribution and numerous transparent vesicles were observed in the cytoplasm of the neurons at the sonicated region, suggesting vesicle-mediated endocytosis. At 48 h after sonication, the expressions of exogenous gene pBDNF-EGFP were observed in the cytoplasm of some neurons, and BDNF expressions were markedly enhanced by the combination of ultrasound and pBDNF-EGFP-loaded microbubbles about 20-fold than that of the control group (P<0.01). The method by using MRI-guided FUS to induce the local BBB disruption could accomplish effective targeted exogenous gene transfer in CNS. This technique may provide a new option for the treatment of various CNS diseases.
本研究旨在探讨 MRI 引导聚焦超声致血脑屏障(BBB)破坏后,向中枢神经系统(CNS)进行靶向基因转染的可行性。在每次超声前,先获取 T2 加权图像以选择靶区。随后将负载 DNA 的微泡经尾静脉注入,再进行超声处理。检测局部 BBB 的状态、通过开放的 BBB 分布的质粒 DNA、神经元的超微结构变化和 BDNF 表达。结果表明,MRI 引导聚焦超声(FUS)可实现非侵入性、瞬时、局部 BBB 破坏,在超声后 1 小时,穿过开放的 BBB 的质粒 DNA 已被内化到神经元中,呈不均匀分布,在超声区域的神经元细胞质中观察到大量透明小泡,提示小泡介导的内吞作用。在超声后 48 小时,观察到一些神经元的细胞质中有外源性基因 pBDNF-EGFP 的表达,并且超声与负载 pBDNF-EGFP 的微泡联合使用后,BDNF 的表达比对照组显著增强约 20 倍(P<0.01)。使用 MRI 引导 FUS 诱导局部 BBB 破坏的方法可以实现在 CNS 中进行有效的靶向外源基因转移。该技术可能为治疗各种 CNS 疾病提供新的选择。